Skip to main content
Login
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

Mass. biotech company facing between 161 and 224 layoffs after FDA rejects drug for 2nd time

Summary by Mass Live
A Woburn biotechnology company is now facing a significantly larger wave of layoffs than initially disclosed — with state filings suggesting between 161 and 224 Massachusetts employees are on the chopping block after federal regulators rejected its lead cancer treatment for the second time.

1 Articles

Mass LiveMass Live
Center

Mass. biotech company facing between 161 and 224 layoffs after FDA rejects drug for 2nd time

A Woburn biotechnology company is now facing a significantly larger wave of layoffs than initially disclosed — with state filings suggesting between 161 and 224 Massachusetts employees are on the chopping block after federal regulators rejected its lead cancer treatment for the second time.

·Springfield, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Mass Live broke the news in Springfield, United States on Monday, April 20, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Layoffs icon

Layoffs

Technology icon

Technology

Woburn, Massachusetts icon

Woburn, Massachusetts

Business & Markets icon

Business & Markets

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal